Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aligos Therapeutics Inc
Swot
Aligos Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aligos Therapeutics Inc has 12 Strengths, 9 Weaknesses, 1 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(9)
Opportunity
(1)
Threats
(3)
Others
(1)
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Profit to Loss Companies
Institutions increasing their shareholding
Stocks rising sharply on very low month volumes
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
